Protective Cooling Measures to Safeguard Elderly People From Dangerous Summer Heat
Evaluating the Efficacy of Cooling Centres for Limiting Heat Strain in Elderly Adults During Extreme Heat Events
1 other identifier
interventional
60
1 country
1
Brief Summary
With the increasing incidence and severity of extreme heat events accompanying climate change, there is an urgent need for sustainable cooling strategies to protect heat-vulnerable older adults, who are at increased risk of adverse health events during heat stress. Health agencies including the World Health Organization, the United States Centers for Disease Control and Prevention, and Health Canada currently recommend visiting a cooling centre or other air-conditioned location for 1-3 hours per day during extreme heat events to mitigate hyperthermia and strain on the cardiovascular system and therefore the risk adverse health events. However, our recent trial shows that while brief air-conditioning exposure is effective for reducing body temperature and cardiovascular burden in healthy older adults, the physiological impacts of cooling abate quickly following return to the heat. The purpose of this project is therefore to assess whether shorter but more frequent air-conditioning exposure provides more effective cooling than current recommendations (a single 1-3-hour cooling bout) in older adults with or without common chronic health conditions associated with increased vulnerability to extreme heat. This will be accomplished by evaluating physiological strain in older adults with and without diabetes and/or hypertension exposed for 8 hours to conditions reflective of extreme heat events in temperate, continental climates (35°C, 60% relative humidity). Participants will complete 3 separate simulated heat event exposures: i) a control trial (no cooling throughout the 8-hour heat event); ii) a recommended cooling trial (3 hours of heat exposure followed by 2 hours cooling); and iii) a hybrid cooling trial (2 hours of heat exposure followed by 1 hour cooling, another 2 hours heat exposure followed by 1 hour cooling, and a final 2-hour heat exposure).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 25, 2022
CompletedFirst Posted
Study publicly available on registry
March 10, 2022
CompletedStudy Start
First participant enrolled
May 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2024
CompletedOctober 21, 2022
October 1, 2022
1 year
February 25, 2022
October 19, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Core temperature (peak)
Peak rectal temperature measured during the 8-hour heat exposure.
8-hour heat exposure
Core temperature (AUC)
Rectal temperature will be measured continuously throughout each exposure and the area under the curve will be calculated.
8-hour heat exposure
Secondary Outcomes (12)
Heart rate temperature (peak)
8-hour heat exposure
Heart rate (AUC)
8-hour heat exposure
Mean skin temperature
Before and continuously throughout each 8 hour exposure
Arterial blood pressures
Every hour during the 8-hour heat exposure
SDNN
Every hour during the 8-hour heat exposure
- +7 more secondary outcomes
Study Arms (3)
Extreme heat event simulation + no cooling (control)
EXPERIMENTALAdults aged 60-85 years with or without type 2 diabetes and/or hypertension
Extreme heat event simulation + recommended cooling
EXPERIMENTALAdults aged 60-85 years with or without type 2 diabetes and/or hypertension
Extreme heat event simulation + hybrid cooling
EXPERIMENTALAdults aged 60-85 years with or without type 2 diabetes and/or hypertension
Interventions
Participants are exposed to 35°C, 60% relative humidity for 8 hours.
Participants are exposed to 35°C, 60% relative humidity for 3 hours, are then moved to an air-conditioned room for 2 hours (\~23°C, \~50% relative humidity), and then return to the heat for a final 3 hours.
Participants are exposed to 35°C, 60% relative humidity for 2 hours, are moved to an air-conditioned room for 1 hour (\~23°C, \~50% relative humidity), return to the heat for 2 hours, move back to the air-conditioned room for 1 hour, and then return to the heat for a final 2 hours
Eligibility Criteria
You may qualify if:
- Adult aged 60-85 years
- Male or female
- Body mass index \< 35 kg/m2
- For participants with type 2 diabetes: at least one year lapsed since diagnosis and hemoglobin A1c 6.0-10.5%.
- For participants with hypertension: at least one year lapsed since diagnosis or average resting blood pressure \>140 systolic or \>90 diastolic
You may not qualify if:
- Currently smoking or quit \<5 years ago
- Moderate or serious medical conditions (other than Type 2 diabetes or high blood pressure), particularly those known to influence physiological responses to heat exposure (e.g., diagnosed heart disease, neurological disorders)
- Heat adapted due to repeated exposure to hot environments (use sauna, recent travel to hot climates, other)
- For participants with type 2 diabetes: "Brittle" diabetes: unpredictable hypo- \& hyperglycemia. Severe cardiovascular autonomic or peripheral neuropathy (guidelines.diabetes.ca/cpg)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Ottawa
Ottawa, Ontario, K1N6N5, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Glen P Kenny, PhD
University of Ottawa
- PRINCIPAL INVESTIGATOR
Ronald J Sigal, MD, MPH
University of Calgary
- PRINCIPAL INVESTIGATOR
Robert D Meade, PhD
University of Ottawa
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Participants will be informed of the study interventions before providing informed consent but will be blinded to the specific trial condition at each of the 3 laboratory visits (control, recommended cooling, hybrid cooling). Data will be blinded prior to analysis.
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Full Professor, University Research Chair
Study Record Dates
First Submitted
February 25, 2022
First Posted
March 10, 2022
Study Start
May 1, 2023
Primary Completion
May 1, 2024
Study Completion
May 1, 2024
Last Updated
October 21, 2022
Record last verified: 2022-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
- Time Frame
- After study completion
- Access Criteria
- Reasonable request and signed access agreement
Deidentified participant data will be available from Dr. Kenny upon reasonable request and signed access agreement.